nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisuride—Pleurisy—Mesalazine—Crohn's disease	0.0251	0.107	CcSEcCtD
Lisuride—Pericardial effusion—Mesalazine—Crohn's disease	0.0149	0.0634	CcSEcCtD
Lisuride—Pericarditis—Mesalazine—Crohn's disease	0.0142	0.0602	CcSEcCtD
Lisuride—Pleural effusion—Mesalazine—Crohn's disease	0.00801	0.034	CcSEcCtD
Lisuride—Dementia—Prednisone—Crohn's disease	0.00791	0.0336	CcSEcCtD
Lisuride—Immune system disorder—Mercaptopurine—Crohn's disease	0.00513	0.0218	CcSEcCtD
Lisuride—Disorientation—Mesalazine—Crohn's disease	0.00498	0.0211	CcSEcCtD
Lisuride—Malnutrition—Mercaptopurine—Crohn's disease	0.00494	0.021	CcSEcCtD
Lisuride—Disturbance in sexual arousal—Mesalazine—Crohn's disease	0.00442	0.0187	CcSEcCtD
Lisuride—Orthostatic hypotension—Mesalazine—Crohn's disease	0.00407	0.0173	CcSEcCtD
Lisuride—Abdominal discomfort—Azathioprine—Crohn's disease	0.00405	0.0172	CcSEcCtD
Lisuride—Anorexia—Mercaptopurine—Crohn's disease	0.00384	0.0163	CcSEcCtD
Lisuride—Abdominal discomfort—Mesalazine—Crohn's disease	0.00369	0.0157	CcSEcCtD
Lisuride—Decreased appetite—Mercaptopurine—Crohn's disease	0.0035	0.0149	CcSEcCtD
Lisuride—Weight increased—Mesalazine—Crohn's disease	0.0035	0.0149	CcSEcCtD
Lisuride—Weight decreased—Mesalazine—Crohn's disease	0.00348	0.0148	CcSEcCtD
Lisuride—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00348	0.0148	CcSEcCtD
Lisuride—Sweating—Mesalazine—Crohn's disease	0.00329	0.014	CcSEcCtD
Lisuride—Immune system disorder—Azathioprine—Crohn's disease	0.00305	0.013	CcSEcCtD
Lisuride—Mediastinal disorder—Azathioprine—Crohn's disease	0.00305	0.0129	CcSEcCtD
Lisuride—Oedema peripheral—Mesalazine—Crohn's disease	0.00303	0.0129	CcSEcCtD
Lisuride—Cardiac disorder—Mesalazine—Crohn's disease	0.00286	0.0121	CcSEcCtD
Lisuride—Angiopathy—Mesalazine—Crohn's disease	0.00279	0.0119	CcSEcCtD
Lisuride—Immune system disorder—Mesalazine—Crohn's disease	0.00278	0.0118	CcSEcCtD
Lisuride—Mediastinal disorder—Mesalazine—Crohn's disease	0.00278	0.0118	CcSEcCtD
Lisuride—Mental disorder—Mesalazine—Crohn's disease	0.0027	0.0115	CcSEcCtD
Lisuride—Vomiting—Mercaptopurine—Crohn's disease	0.00256	0.0109	CcSEcCtD
Lisuride—Vertigo—Mesalazine—Crohn's disease	0.00241	0.0102	CcSEcCtD
Lisuride—Syncope—Mesalazine—Crohn's disease	0.0024	0.0102	CcSEcCtD
Lisuride—Infection—Azathioprine—Crohn's disease	0.00239	0.0101	CcSEcCtD
Lisuride—Palpitations—Mesalazine—Crohn's disease	0.00237	0.0101	CcSEcCtD
Lisuride—Cough—Mesalazine—Crohn's disease	0.00234	0.00993	CcSEcCtD
Lisuride—Anxiety—Mesalazine—Crohn's disease	0.00227	0.00965	CcSEcCtD
Lisuride—Dry mouth—Mesalazine—Crohn's disease	0.00223	0.00947	CcSEcCtD
Lisuride—Confusional state—Mesalazine—Crohn's disease	0.00221	0.00936	CcSEcCtD
Lisuride—Infection—Mesalazine—Crohn's disease	0.00217	0.00922	CcSEcCtD
Lisuride—Nervous system disorder—Mesalazine—Crohn's disease	0.00215	0.00911	CcSEcCtD
Lisuride—Tachycardia—Mesalazine—Crohn's disease	0.00214	0.00906	CcSEcCtD
Lisuride—Hyperhidrosis—Mesalazine—Crohn's disease	0.00212	0.00898	CcSEcCtD
Lisuride—Anorexia—Mesalazine—Crohn's disease	0.00209	0.00885	CcSEcCtD
Lisuride—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.00207	0.0088	CcSEcCtD
Lisuride—Feeling abnormal—Azathioprine—Crohn's disease	0.00198	0.0084	CcSEcCtD
Lisuride—Insomnia—Mesalazine—Crohn's disease	0.00198	0.0084	CcSEcCtD
Lisuride—Dyspnoea—Mesalazine—Crohn's disease	0.00195	0.00828	CcSEcCtD
Lisuride—Somnolence—Mesalazine—Crohn's disease	0.00195	0.00825	CcSEcCtD
Lisuride—Decreased appetite—Mesalazine—Crohn's disease	0.0019	0.00807	CcSEcCtD
Lisuride—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.00189	0.00802	CcSEcCtD
Lisuride—Fatigue—Mesalazine—Crohn's disease	0.00189	0.00801	CcSEcCtD
Lisuride—Constipation—Mesalazine—Crohn's disease	0.00187	0.00794	CcSEcCtD
Lisuride—Weight increased—Prednisone—Crohn's disease	0.00185	0.00786	CcSEcCtD
Lisuride—Weight decreased—Prednisone—Crohn's disease	0.00184	0.00782	CcSEcCtD
Lisuride—Feeling abnormal—Mesalazine—Crohn's disease	0.0018	0.00765	CcSEcCtD
Lisuride—Hallucination—Prednisone—Crohn's disease	0.00162	0.00688	CcSEcCtD
Lisuride—Dizziness—Azathioprine—Crohn's disease	0.00159	0.00674	CcSEcCtD
Lisuride—Asthenia—Mesalazine—Crohn's disease	0.00157	0.00666	CcSEcCtD
Lisuride—Vomiting—Azathioprine—Crohn's disease	0.00153	0.00648	CcSEcCtD
Lisuride—Headache—Azathioprine—Crohn's disease	0.0015	0.00639	CcSEcCtD
Lisuride—Angiopathy—Prednisone—Crohn's disease	0.00148	0.00627	CcSEcCtD
Lisuride—Immune system disorder—Prednisone—Crohn's disease	0.00147	0.00625	CcSEcCtD
Lisuride—Dizziness—Mesalazine—Crohn's disease	0.00145	0.00614	CcSEcCtD
Lisuride—Mental disorder—Prednisone—Crohn's disease	0.00143	0.00606	CcSEcCtD
Lisuride—Malnutrition—Prednisone—Crohn's disease	0.00142	0.00602	CcSEcCtD
Lisuride—Vomiting—Mesalazine—Crohn's disease	0.00139	0.0059	CcSEcCtD
Lisuride—Headache—Mesalazine—Crohn's disease	0.00137	0.00582	CcSEcCtD
Lisuride—Vertigo—Prednisone—Crohn's disease	0.00127	0.00541	CcSEcCtD
Lisuride—Syncope—Prednisone—Crohn's disease	0.00127	0.0054	CcSEcCtD
Lisuride—Anxiety—Prednisone—Crohn's disease	0.0012	0.00511	CcSEcCtD
Lisuride—Infection—Prednisone—Crohn's disease	0.00115	0.00488	CcSEcCtD
Lisuride—Nervous system disorder—Prednisone—Crohn's disease	0.00114	0.00482	CcSEcCtD
Lisuride—Tachycardia—Prednisone—Crohn's disease	0.00113	0.00479	CcSEcCtD
Lisuride—Hyperhidrosis—Prednisone—Crohn's disease	0.00112	0.00475	CcSEcCtD
Lisuride—Anorexia—Prednisone—Crohn's disease	0.0011	0.00468	CcSEcCtD
Lisuride—Insomnia—Prednisone—Crohn's disease	0.00105	0.00444	CcSEcCtD
Lisuride—Decreased appetite—Prednisone—Crohn's disease	0.00101	0.00427	CcSEcCtD
Lisuride—Fatigue—Prednisone—Crohn's disease	0.000998	0.00424	CcSEcCtD
Lisuride—Constipation—Prednisone—Crohn's disease	0.00099	0.0042	CcSEcCtD
Lisuride—Feeling abnormal—Prednisone—Crohn's disease	0.000954	0.00405	CcSEcCtD
Lisuride—Asthenia—Prednisone—Crohn's disease	0.000831	0.00352	CcSEcCtD
Lisuride—Dizziness—Prednisone—Crohn's disease	0.000765	0.00325	CcSEcCtD
Lisuride—Vomiting—Prednisone—Crohn's disease	0.000736	0.00312	CcSEcCtD
Lisuride—Headache—Prednisone—Crohn's disease	0.000725	0.00308	CcSEcCtD
Lisuride—CYP2D6—Metabolism—GPX4—Crohn's disease	0.000139	0.000182	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—UBE2D1—Crohn's disease	0.000139	0.000181	CbGpPWpGaD
Lisuride—DRD3—GPCR downstream signaling—JAK2—Crohn's disease	0.000139	0.000181	CbGpPWpGaD
Lisuride—ADRA1D—GPCR downstream signaling—JAK2—Crohn's disease	0.000139	0.000181	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—SOCS1—Crohn's disease	0.000138	0.000181	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—SOCS1—Crohn's disease	0.000138	0.000181	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—RASGRP1—Crohn's disease	0.000138	0.00018	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—IL3—Crohn's disease	0.000138	0.00018	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—IL3—Crohn's disease	0.000137	0.000179	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—SMAD3—Crohn's disease	0.000137	0.000179	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—RIPK2—Crohn's disease	0.000137	0.000179	CbGpPWpGaD
Lisuride—HTR2B—GPCR downstream signaling—CXCL8—Crohn's disease	0.000136	0.000178	CbGpPWpGaD
Lisuride—HTR2B—Signaling by GPCR—JAK2—Crohn's disease	0.000135	0.000177	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—SMAD3—Crohn's disease	0.000135	0.000176	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—RIPK2—Crohn's disease	0.000134	0.000176	CbGpPWpGaD
Lisuride—HTR1D—Signaling by GPCR—CXCL8—Crohn's disease	0.000134	0.000176	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—GCKR—Crohn's disease	0.000134	0.000176	CbGpPWpGaD
Lisuride—DRD1—Signaling by GPCR—TYK2—Crohn's disease	0.000134	0.000175	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—IL3—Crohn's disease	0.000133	0.000174	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—RASGRP1—Crohn's disease	0.000133	0.000174	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—RASGRP1—Crohn's disease	0.000132	0.000173	CbGpPWpGaD
Lisuride—ADRA1D—Signaling by GPCR—TYK2—Crohn's disease	0.000132	0.000173	CbGpPWpGaD
Lisuride—DRD3—Signaling by GPCR—TYK2—Crohn's disease	0.000132	0.000173	CbGpPWpGaD
Lisuride—HTR1B—Signaling by GPCR—CXCL8—Crohn's disease	0.000131	0.000172	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—IL3—Crohn's disease	0.000131	0.000172	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—RBX1—Crohn's disease	0.00013	0.000171	CbGpPWpGaD
Lisuride—DRD4—Signaling by GPCR—CXCL8—Crohn's disease	0.000129	0.000169	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—IL2RA—Crohn's disease	0.000129	0.000169	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—RASGRP1—Crohn's disease	0.000129	0.000169	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—SMAD3—Crohn's disease	0.000128	0.000168	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—IL2RA—Crohn's disease	0.000128	0.000168	CbGpPWpGaD
Lisuride—DRD1—GPCR downstream signaling—CXCL8—Crohn's disease	0.000128	0.000168	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—UBE2D1—Crohn's disease	0.000128	0.000167	CbGpPWpGaD
Lisuride—DRD1—Signaling by GPCR—JAK2—Crohn's disease	0.000128	0.000167	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—PTGER4—Crohn's disease	0.000127	0.000166	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—RASGRP1—Crohn's disease	0.000127	0.000166	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—IL2RA—Crohn's disease	0.000127	0.000166	CbGpPWpGaD
Lisuride—DRD3—GPCR downstream signaling—CXCL8—Crohn's disease	0.000127	0.000166	CbGpPWpGaD
Lisuride—ADRA1D—GPCR downstream signaling—CXCL8—Crohn's disease	0.000127	0.000166	CbGpPWpGaD
Lisuride—ADRB1—GPCR downstream signaling—JAK2—Crohn's disease	0.000126	0.000165	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—SOCS1—Crohn's disease	0.000126	0.000165	CbGpPWpGaD
Lisuride—ADRA1D—Signaling by GPCR—JAK2—Crohn's disease	0.000126	0.000165	CbGpPWpGaD
Lisuride—DRD3—Signaling by GPCR—JAK2—Crohn's disease	0.000126	0.000165	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—UBE2D1—Crohn's disease	0.000126	0.000165	CbGpPWpGaD
Lisuride—ADRA2B—GPCR downstream signaling—JAK2—Crohn's disease	0.000125	0.000164	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—SOCS1—Crohn's disease	0.000125	0.000163	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—IL2RA—Crohn's disease	0.000125	0.000163	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—MTMR3—Crohn's disease	0.000125	0.000163	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—RIPK2—Crohn's disease	0.000124	0.000162	CbGpPWpGaD
Lisuride—HTR2B—Signaling by GPCR—CXCL8—Crohn's disease	0.000123	0.000162	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—RIPK2—Crohn's disease	0.000122	0.00016	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—SMAD3—Crohn's disease	0.000121	0.000158	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—IL3—Crohn's disease	0.000121	0.000158	CbGpPWpGaD
Lisuride—HTR1A—GPCR downstream signaling—JAK2—Crohn's disease	0.000121	0.000158	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—SOCS1—Crohn's disease	0.000121	0.000158	CbGpPWpGaD
Lisuride—ADRB1—Signaling by GPCR—TYK2—Crohn's disease	0.00012	0.000157	CbGpPWpGaD
Lisuride—HTR2C—GPCR downstream signaling—JAK2—Crohn's disease	0.00012	0.000157	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—SOCS1—Crohn's disease	0.00012	0.000157	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—SMAD3—Crohn's disease	0.00012	0.000156	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—SMAD3—Crohn's disease	0.00012	0.000156	CbGpPWpGaD
Lisuride—ADRA2B—Signaling by GPCR—TYK2—Crohn's disease	0.000119	0.000156	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—IL3—Crohn's disease	0.000119	0.000156	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—TYK2—Crohn's disease	0.000119	0.000156	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—IL2RA—Crohn's disease	0.000119	0.000156	CbGpPWpGaD
Lisuride—ADRA2C—GPCR downstream signaling—JAK2—Crohn's disease	0.000117	0.000153	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—RASGRP1—Crohn's disease	0.000117	0.000153	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—SOCS1—Crohn's disease	0.000117	0.000153	CbGpPWpGaD
Lisuride—DRD1—Signaling by GPCR—CXCL8—Crohn's disease	0.000116	0.000152	CbGpPWpGaD
Lisuride—ADRB1—GPCR downstream signaling—CXCL8—Crohn's disease	0.000115	0.000151	CbGpPWpGaD
Lisuride—ADRA1B—GPCR downstream signaling—JAK2—Crohn's disease	0.000115	0.000151	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—RASGRP1—Crohn's disease	0.000115	0.000151	CbGpPWpGaD
Lisuride—HTR1A—Signaling by GPCR—TYK2—Crohn's disease	0.000115	0.00015	CbGpPWpGaD
Lisuride—ADRA1D—Signaling by GPCR—CXCL8—Crohn's disease	0.000115	0.00015	CbGpPWpGaD
Lisuride—DRD3—Signaling by GPCR—CXCL8—Crohn's disease	0.000115	0.00015	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—SOCS1—Crohn's disease	0.000115	0.00015	CbGpPWpGaD
Lisuride—ADRB1—Signaling by GPCR—JAK2—Crohn's disease	0.000115	0.00015	CbGpPWpGaD
Lisuride—HTR2C—Signaling by GPCR—TYK2—Crohn's disease	0.000114	0.00015	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—UBE2D1—Crohn's disease	0.000114	0.00015	CbGpPWpGaD
Lisuride—ADRA2B—GPCR downstream signaling—CXCL8—Crohn's disease	0.000114	0.000149	CbGpPWpGaD
Lisuride—ADRA2B—Signaling by GPCR—JAK2—Crohn's disease	0.000114	0.000149	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—JAK2—Crohn's disease	0.000113	0.000148	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—IL2RA—Crohn's disease	0.000112	0.000147	CbGpPWpGaD
Lisuride—ADRA2C—Signaling by GPCR—TYK2—Crohn's disease	0.000111	0.000146	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—RIPK2—Crohn's disease	0.000111	0.000145	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—IL2RA—Crohn's disease	0.000111	0.000145	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—IL2RA—Crohn's disease	0.000111	0.000145	CbGpPWpGaD
Lisuride—HTR1A—GPCR downstream signaling—CXCL8—Crohn's disease	0.00011	0.000144	CbGpPWpGaD
Lisuride—HTR1A—Signaling by GPCR—JAK2—Crohn's disease	0.00011	0.000144	CbGpPWpGaD
Lisuride—HTR2C—GPCR downstream signaling—CXCL8—Crohn's disease	0.00011	0.000144	CbGpPWpGaD
Lisuride—ADRA1B—Signaling by GPCR—TYK2—Crohn's disease	0.00011	0.000143	CbGpPWpGaD
Lisuride—HTR2C—Signaling by GPCR—JAK2—Crohn's disease	0.000109	0.000143	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—SMAD3—Crohn's disease	0.000109	0.000142	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—IL3—Crohn's disease	0.000108	0.000142	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—SMAD3—Crohn's disease	0.000108	0.000141	CbGpPWpGaD
Lisuride—ADRA2C—GPCR downstream signaling—CXCL8—Crohn's disease	0.000107	0.00014	CbGpPWpGaD
Lisuride—ADRA2C—Signaling by GPCR—JAK2—Crohn's disease	0.000106	0.000139	CbGpPWpGaD
Lisuride—DRD2—GPCR downstream signaling—JAK2—Crohn's disease	0.000106	0.000139	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—SOCS1—Crohn's disease	0.000106	0.000139	CbGpPWpGaD
Lisuride—ADRA1B—GPCR downstream signaling—CXCL8—Crohn's disease	0.000105	0.000137	CbGpPWpGaD
Lisuride—ADRB1—Signaling by GPCR—CXCL8—Crohn's disease	0.000105	0.000137	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—RASGRP1—Crohn's disease	0.000105	0.000137	CbGpPWpGaD
Lisuride—ADRA1B—Signaling by GPCR—JAK2—Crohn's disease	0.000105	0.000137	CbGpPWpGaD
Lisuride—HTR2A—GPCR downstream signaling—JAK2—Crohn's disease	0.000104	0.000137	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—SOCS1—Crohn's disease	0.000104	0.000136	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—SMAD3—Crohn's disease	0.000104	0.000136	CbGpPWpGaD
Lisuride—ADRA2B—Signaling by GPCR—CXCL8—Crohn's disease	0.000104	0.000136	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—SMAD3—Crohn's disease	0.000104	0.000136	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—CXCL8—Crohn's disease	0.000104	0.000135	CbGpPWpGaD
Lisuride—DRD2—Signaling by GPCR—TYK2—Crohn's disease	0.000101	0.000132	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—IL2RA—Crohn's disease	0.000101	0.000132	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—SMAD3—Crohn's disease	0.000101	0.000132	CbGpPWpGaD
Lisuride—HTR1A—Signaling by GPCR—CXCL8—Crohn's disease	0.0001	0.000131	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—IL2RA—Crohn's disease	9.99e-05	0.000131	CbGpPWpGaD
Lisuride—HTR2C—Signaling by GPCR—CXCL8—Crohn's disease	9.96e-05	0.00013	CbGpPWpGaD
Lisuride—HTR2A—Signaling by GPCR—TYK2—Crohn's disease	9.94e-05	0.00013	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—SMAD3—Crohn's disease	9.92e-05	0.00013	CbGpPWpGaD
Lisuride—DRD5—Signaling by GPCR—IL6—Crohn's disease	9.85e-05	0.000129	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—FADS1—Crohn's disease	9.7e-05	0.000127	CbGpPWpGaD
Lisuride—ADRA2C—Signaling by GPCR—CXCL8—Crohn's disease	9.69e-05	0.000127	CbGpPWpGaD
Lisuride—DRD2—GPCR downstream signaling—CXCL8—Crohn's disease	9.68e-05	0.000127	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—IL2RA—Crohn's disease	9.64e-05	0.000126	CbGpPWpGaD
Lisuride—DRD2—Signaling by GPCR—JAK2—Crohn's disease	9.63e-05	0.000126	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—IL2RA—Crohn's disease	9.59e-05	0.000126	CbGpPWpGaD
Lisuride—ADRA1B—Signaling by GPCR—CXCL8—Crohn's disease	9.54e-05	0.000125	CbGpPWpGaD
Lisuride—HTR2A—GPCR downstream signaling—CXCL8—Crohn's disease	9.53e-05	0.000125	CbGpPWpGaD
Lisuride—ADRA2A—GPCR downstream signaling—JAK2—Crohn's disease	9.5e-05	0.000124	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—SOCS1—Crohn's disease	9.48e-05	0.000124	CbGpPWpGaD
Lisuride—HTR2A—Signaling by GPCR—JAK2—Crohn's disease	9.48e-05	0.000124	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—IL2RA—Crohn's disease	9.33e-05	0.000122	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—IL2RA—Crohn's disease	9.18e-05	0.00012	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—SMAD3—Crohn's disease	9.15e-05	0.00012	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—TYK2—Crohn's disease	9.11e-05	0.000119	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—GPX4—Crohn's disease	9.08e-05	0.000119	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—TYK2—Crohn's disease	9.04e-05	0.000118	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—SMAD3—Crohn's disease	9e-05	0.000118	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—TYK2—Crohn's disease	8.92e-05	0.000117	CbGpPWpGaD
Lisuride—DRD2—Signaling by GPCR—CXCL8—Crohn's disease	8.79e-05	0.000115	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—TYK2—Crohn's disease	8.78e-05	0.000115	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—GCKR—Crohn's disease	8.77e-05	0.000115	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—JAK2—Crohn's disease	8.69e-05	0.000114	CbGpPWpGaD
Lisuride—ADRA2A—GPCR downstream signaling—CXCL8—Crohn's disease	8.67e-05	0.000113	CbGpPWpGaD
Lisuride—HTR2A—Signaling by GPCR—CXCL8—Crohn's disease	8.65e-05	0.000113	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—JAK2—Crohn's disease	8.62e-05	0.000113	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—JAK2—Crohn's disease	8.51e-05	0.000111	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—IL2RA—Crohn's disease	8.47e-05	0.000111	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—TYK2—Crohn's disease	8.38e-05	0.00011	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—JAK2—Crohn's disease	8.37e-05	0.00011	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—IL2RA—Crohn's disease	8.33e-05	0.000109	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—STAT3—Crohn's disease	8.33e-05	0.000109	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—SMAD3—Crohn's disease	8.19e-05	0.000107	CbGpPWpGaD
Lisuride—ADRA2C—Metabolism—ALB—Crohn's disease	8.07e-05	0.000106	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—JAK2—Crohn's disease	7.99e-05	0.000105	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—CXCL8—Crohn's disease	7.93e-05	0.000104	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—TYK2—Crohn's disease	7.9e-05	0.000103	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—CXCL8—Crohn's disease	7.87e-05	0.000103	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—TYK2—Crohn's disease	7.8e-05	0.000102	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—TYK2—Crohn's disease	7.8e-05	0.000102	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—CXCL8—Crohn's disease	7.77e-05	0.000102	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—CXCL8—Crohn's disease	7.64e-05	0.0001	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—IL2RA—Crohn's disease	7.58e-05	9.92e-05	CbGpPWpGaD
Lisuride—HTR1D—Signaling by GPCR—IL6—Crohn's disease	7.54e-05	9.87e-05	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—JAK2—Crohn's disease	7.54e-05	9.86e-05	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—JAK2—Crohn's disease	7.44e-05	9.73e-05	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—JAK2—Crohn's disease	7.44e-05	9.73e-05	CbGpPWpGaD
Lisuride—HTR1B—Signaling by GPCR—IL6—Crohn's disease	7.39e-05	9.66e-05	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—CXCL8—Crohn's disease	7.3e-05	9.54e-05	CbGpPWpGaD
Lisuride—DRD4—Signaling by GPCR—IL6—Crohn's disease	7.27e-05	9.51e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—TYK2—Crohn's disease	7.1e-05	9.29e-05	CbGpPWpGaD
Lisuride—ADRA2C—Metabolism—PTGS2—Crohn's disease	7.06e-05	9.24e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—TYK2—Crohn's disease	7.04e-05	9.21e-05	CbGpPWpGaD
Lisuride—HTR2B—Signaling by GPCR—IL6—Crohn's disease	6.94e-05	9.08e-05	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—CXCL8—Crohn's disease	6.88e-05	9e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—TYK2—Crohn's disease	6.79e-05	8.89e-05	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—CXCL8—Crohn's disease	6.79e-05	8.88e-05	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—CXCL8—Crohn's disease	6.79e-05	8.88e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—JAK2—Crohn's disease	6.78e-05	8.87e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—TYK2—Crohn's disease	6.76e-05	8.84e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—JAK2—Crohn's disease	6.72e-05	8.79e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—TYK2—Crohn's disease	6.58e-05	8.6e-05	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—ALB—Crohn's disease	6.55e-05	8.57e-05	CbGpPWpGaD
Lisuride—DRD1—Signaling by GPCR—IL6—Crohn's disease	6.54e-05	8.56e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—JAK2—Crohn's disease	6.48e-05	8.48e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—TYK2—Crohn's disease	6.47e-05	8.47e-05	CbGpPWpGaD
Lisuride—ADRA1D—Signaling by GPCR—IL6—Crohn's disease	6.46e-05	8.45e-05	CbGpPWpGaD
Lisuride—DRD3—Signaling by GPCR—IL6—Crohn's disease	6.46e-05	8.45e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—JAK2—Crohn's disease	6.45e-05	8.44e-05	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—STAT3—Crohn's disease	6.38e-05	8.34e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—JAK2—Crohn's disease	6.27e-05	8.21e-05	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—STAT3—Crohn's disease	6.25e-05	8.17e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—CXCL8—Crohn's disease	6.19e-05	8.09e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—JAK2—Crohn's disease	6.17e-05	8.08e-05	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—STAT3—Crohn's disease	6.15e-05	8.04e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—CXCL8—Crohn's disease	6.13e-05	8.02e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—TYK2—Crohn's disease	5.97e-05	7.81e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—CXCL8—Crohn's disease	5.92e-05	7.74e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—CXCL8—Crohn's disease	5.89e-05	7.7e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling by GPCR—IL6—Crohn's disease	5.88e-05	7.69e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—TYK2—Crohn's disease	5.87e-05	7.68e-05	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—STAT3—Crohn's disease	5.87e-05	7.68e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling by GPCR—IL6—Crohn's disease	5.83e-05	7.62e-05	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—IL6—Crohn's disease	5.82e-05	7.61e-05	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—PTGS2—Crohn's disease	5.73e-05	7.5e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—CXCL8—Crohn's disease	5.72e-05	7.49e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—JAK2—Crohn's disease	5.69e-05	7.45e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—CXCL8—Crohn's disease	5.63e-05	7.37e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling by GPCR—IL6—Crohn's disease	5.63e-05	7.36e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—JAK2—Crohn's disease	5.6e-05	7.33e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling by GPCR—IL6—Crohn's disease	5.6e-05	7.32e-05	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—STAT3—Crohn's disease	5.53e-05	7.24e-05	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—STAT3—Crohn's disease	5.46e-05	7.14e-05	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—STAT3—Crohn's disease	5.46e-05	7.14e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling by GPCR—IL6—Crohn's disease	5.44e-05	7.12e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling by GPCR—IL6—Crohn's disease	5.36e-05	7.01e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—TYK2—Crohn's disease	5.34e-05	6.99e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—CXCL8—Crohn's disease	5.19e-05	6.8e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—CXCL8—Crohn's disease	5.11e-05	6.69e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—JAK2—Crohn's disease	5.09e-05	6.67e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—STAT3—Crohn's disease	4.97e-05	6.51e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling by GPCR—IL6—Crohn's disease	4.94e-05	6.46e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—STAT3—Crohn's disease	4.93e-05	6.45e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling by GPCR—IL6—Crohn's disease	4.86e-05	6.36e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—STAT3—Crohn's disease	4.76e-05	6.22e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—STAT3—Crohn's disease	4.73e-05	6.19e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—CXCL8—Crohn's disease	4.65e-05	6.08e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—STAT3—Crohn's disease	4.6e-05	6.02e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—STAT3—Crohn's disease	4.53e-05	5.93e-05	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—IL6—Crohn's disease	4.46e-05	5.83e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—IL6—Crohn's disease	4.42e-05	5.78e-05	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—IL6—Crohn's disease	4.36e-05	5.71e-05	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—IL6—Crohn's disease	4.29e-05	5.62e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—ALB—Crohn's disease	4.27e-05	5.59e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—STAT3—Crohn's disease	4.18e-05	5.47e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—STAT3—Crohn's disease	4.11e-05	5.38e-05	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—IL6—Crohn's disease	4.1e-05	5.36e-05	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—IL6—Crohn's disease	3.86e-05	5.06e-05	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—IL6—Crohn's disease	3.81e-05	4.99e-05	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—IL6—Crohn's disease	3.81e-05	4.99e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—STAT3—Crohn's disease	3.74e-05	4.89e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—PTGS2—Crohn's disease	3.74e-05	4.89e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—IL6—Crohn's disease	3.47e-05	4.55e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—IL6—Crohn's disease	3.44e-05	4.5e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—IL6—Crohn's disease	3.32e-05	4.35e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—IL6—Crohn's disease	3.31e-05	4.33e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—IL6—Crohn's disease	3.22e-05	4.21e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—IL6—Crohn's disease	3.16e-05	4.14e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—IL6—Crohn's disease	2.92e-05	3.82e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—IL6—Crohn's disease	2.87e-05	3.76e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—ALB—Crohn's disease	2.79e-05	3.65e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—IL6—Crohn's disease	2.61e-05	3.42e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—PTGS2—Crohn's disease	2.44e-05	3.2e-05	CbGpPWpGaD
